Dostarlimab in combination with chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: a placebo-controlled randomized phase 3 trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

GYNECOLOGIC ONCOLOGY(2023)

引用 0|浏览11
暂无评分
关键词
recurrent endometrial cancer,chemotherapy,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要